These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

910 related items for PubMed ID: 19947169

  • 1. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
    Xu HB, Li L, Liu GQ.
    Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169
    [Abstract] [Full Text] [Related]

  • 2. Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells.
    Shi YQ, Qu XJ, Liao YX, Xie CF, Cheng YN, Li S, Lou HX.
    Eur J Pharmacol; 2008 Apr 14; 584(1):66-71. PubMed ID: 18304528
    [Abstract] [Full Text] [Related]

  • 3. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X, Sun B, Zhu CJ, Yuan HQ, Shi YQ, Gao J, Li SJ, Lou HX.
    Toxicol In Vitro; 2009 Feb 14; 23(1):29-36. PubMed ID: 18938236
    [Abstract] [Full Text] [Related]

  • 4. The synergistic reversal effect of multidrug resistance by quercetin and hyperthermia in doxorubicin-resistant human myelogenous leukemia cells.
    Shen J, Zhang W, Wu J, Zhu Y.
    Int J Hyperthermia; 2008 Mar 14; 24(2):151-9. PubMed ID: 18283591
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, Gu LQ, Yang XP, Fu LW.
    J Pharm Pharmacol; 2004 Aug 14; 56(8):1061-6. PubMed ID: 15285852
    [Abstract] [Full Text] [Related]

  • 10. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2002 May 14; 49(5):391-7. PubMed ID: 11976833
    [Abstract] [Full Text] [Related]

  • 11. Reversion of P-glycoprotein-mediated multidrug resistance by guggulsterone in multidrug-resistant human cancer cell lines.
    Xu HB, Xu LZ, Li L, Fu J, Mao XP.
    Eur J Pharmacol; 2012 Nov 05; 694(1-3):39-44. PubMed ID: 22960326
    [Abstract] [Full Text] [Related]

  • 12. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
    Fang W, Li Y, Cai Y, Kang K, Yan F, Liu G, Huang W.
    J Pharm Pharmacol; 2007 Dec 05; 59(12):1649-55. PubMed ID: 18053326
    [Abstract] [Full Text] [Related]

  • 13. Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
    Ji BS, He L, Liu GQ.
    Life Sci; 2005 Sep 16; 77(18):2221-32. PubMed ID: 15967469
    [Abstract] [Full Text] [Related]

  • 14. Reduction of doxorubicin resistance in P-glycoprotein overexpressing cells by hybrid cell-penetrating and drug-binding peptide.
    Zheng Z, Aojula H, Clarke D.
    J Drug Target; 2010 Jul 16; 18(6):477-87. PubMed ID: 20088680
    [Abstract] [Full Text] [Related]

  • 15. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
    Xiang W, Gao A, Liang H, Li C, Gao J, Wang Q, Shuang B, Zhang J, Yan Y, Wang X.
    Toxicol In Vitro; 2010 Sep 16; 24(6):1474-81. PubMed ID: 20656007
    [Abstract] [Full Text] [Related]

  • 16. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
    Tang XQ, Bi H, Feng JQ, Cao JG.
    Acta Pharmacol Sin; 2005 Aug 16; 26(8):1009-16. PubMed ID: 16038636
    [Abstract] [Full Text] [Related]

  • 17. Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.
    Li GY, Liu JZ, Zhang B, Wang LX, Wang CB, Chen SG.
    Biomed Pharmacother; 2009 Sep 16; 63(8):566-70. PubMed ID: 19095404
    [Abstract] [Full Text] [Related]

  • 18. Reversal effect of Ganoderma lucidum polysaccharide on multidrug resistance in K562/ADM cell line.
    Li WD, Zhang BD, Wei R, Liu JH, Lin ZB.
    Acta Pharmacol Sin; 2008 May 16; 29(5):620-7. PubMed ID: 18430371
    [Abstract] [Full Text] [Related]

  • 19. Reversal of cancer multidrug resistance by green tea polyphenols.
    Mei Y, Qian F, Wei D, Liu J.
    J Pharm Pharmacol; 2004 Oct 16; 56(10):1307-14. PubMed ID: 15482646
    [Abstract] [Full Text] [Related]

  • 20. P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells.
    Li R, Wu R, Zhao L, Wu M, Yang L, Zou H.
    ACS Nano; 2010 Mar 23; 4(3):1399-408. PubMed ID: 20148593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.